0R2B.L

Danaher Corporation [0R2B.L] Stock Forecast

Q: What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock, located in Washington of Dc and trading under the symbol 0R2B.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0R2B.L Stock Summary

Earnings are expected to rise 27.65% next year

0R2B.L has more than 44 years of cash runway (537 months)

Unstable dividend track record

0R2B.L's dividend payments are not well covered by cash flows due to its high cash payout ratio (454.52%).

Top 10 Correlated ETFs

0R2B.L

Top 10 Correlated Stocks

0R2B.L

In the News

0R2B.L Financial details

Company Rating

Buy

Market Cap

177.92B

Income

4.76B

Revenue

27.6B

Book val./share

72.3

Cash/share

7.93

Dividend

29.24

Dividend %

12.66%

Employees

61K

Optionable

Shortable

Yes

Earnings

23 Apr 2024

P/E

29.39

Forward P/E

27.45

PEG

-8.44

P/S

5.77

P/B

3.29

P/C

30.04

P/FCF

25.18

Quick Ratio

1.77

Current Ratio

2.26

Debt / Equity

0.35

LT Debt / Equity

0.31

EPS (TTM)

6.48

EPS next Y

8.68

EPS next Q

1.91

EPS this Y

-34.91%

EPS next Y

33.89%

EPS next 5Y

83.56%

EPS last 5Y

12.57%

Revenue last 5Y

5.93%

Revenue Q/Q

-6.81%

EPS Q/Q

-4.58%

SMA20

-4.03%

SMA50

3.7%

SMA100

21.22%

Inst Own

Inst Trans

ROA

ROE

11%

ROC

0.09%

Gross Margin

59%

Oper. Margin

24%

Profit Margin

20%

Payout

14%

Shs Outstand

740.54M

Shs Float

675.16M

Target Price

52W Range

182.1646-269.2343

52W High

-11.44%

52W Low

+30.9%

RSI

33.78

Rel Volume

0.15

Avg Volume

37.09K

Volume

5.62K

Perf Week

-3.23%

Perf Month

-6.26%

Perf Quarter

14.06%

Perf Half Y

12.84%

Beta

0.86

Volatility

3.13%, 4.92%

Prev Close

-0.45%

Price

238.23

Change

-1.71%

0R2B.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	25.05	31.55	41.22	36.74	32.44
Net income per share	3.58	5.16	9	9.94	6.47
Operating cash flow per share	5.53	8.79	11.7	11.75	9.73
Free cash flow per share	4.64	7.67	9.89	10.21	7.85
Cash per share	27.85	8.55	3.62	8.27	7.96
Book value per share	42.34	56.31	63.21	69.07	72.62
Tangible book value per share	-3.05	-23.97	-26.38	-9.66	-12.04
Share holders equity per share	42.34	56.31	63.21	69.07	72.62
Interest debt per share	30.74	30.68	31.66	27.65	25.62
Market cap	97.4B	138.65B	207.56B	169.22B	172.21B
Enterprise value	100.01B	154.79B	228.25B	183.84B	185.88B
P/E ratio	38.09	38.03	32.27	23.47	36.15
Price to sales ratio	5.44	6.22	7.05	6.35	7.21
POCF ratio	24.65	22.33	24.83	19.86	24.04
PFCF ratio	29.37	25.6	29.38	22.86	29.79
P/B Ratio	3.22	3.49	4.6	3.38	3.22
PTB ratio	3.22	3.49	4.6	3.38	3.22
EV to sales	5.58	6.95	7.75	6.9	7.78
Enterprise value over EBITDA	21.97	25.43	22.34	19.02	24.97
EV to operating cash flow	25.31	24.93	27.31	21.58	25.95
EV to free cash flow	30.16	28.58	32.31	24.84	32.15
Earnings yield	0.03	0.03	0.03	0.04	0.03
Free cash flow yield	0.03	0.04	0.03	0.04	0.03
Debt to equity	0.72	0.54	0.5	0.4	0.35
Debt to assets	0.35	0.28	0.27	0.24	0.22
Net debt to EBITDA	0.57	2.65	2.02	1.51	1.84
Current ratio	5.19	1.86	1.43	1.89	1.68
Interest coverage	30.96	15.79	33.4	36.41	18.27
Income quality	1.62	1.7	1.32	1.35	1.7
Dividend Yield	0.01	0	0	0	0
Payout ratio	0.21	0.17	0.12	0.11	0.17
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.06	0.06	0.06	0.06	0.06
Intangibles to total assets	0.52	0.74	0.77	0.68	0.74
Capex to operating cash flow	-0.16	-0.13	-0.15	-0.13	-0.19
Capex to revenue	-0.04	-0.04	-0.04	-0.04	-0.06
Capex to depreciation	-0.53	-0.45	-0.6	-0.52	-0.64
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	58.37	80.88	113.15	124.3	102.81
ROIC	0.05	0.06	0.1	0.09	0.06
Return on tangible assets	0.09	0.19	0.34	0.26	0.22
Graham Net	-12.06	-36.24	-41.92	-31.84	-27.64
Working capital	20.66B	6.4B	3.51B	7.49B	5.66B
Tangible asset value	-2.18B	-16.93B	-18.85B	-7.01B	-8.86B
Net current asset value	-6.2B	-22.58B	-26.36B	-18.38B	-17.06B
Invested capital	0.72	0.54	0.5	0.4	0.35
Average receivables	3.19B	4.04B	5.13B	5.25B	4.85B
Average payables	1.5B	1.78B	2.31B	2.21B	1.81B
Average inventory	1.63B	1.96B	2.53B	2.77B	2.68B
Days sales outstanding	66.6	78.79	67.45	69.38	70.85
Days payables outstanding	69.73	76.24	81.53	64.8	65.4
Days of inventory on hand	74.97	85.29	87.81	96.53	96.06
Receivables turnover	5.48	4.63	5.41	5.26	5.15
Payables turnover	5.23	4.79	4.48	5.63	5.58
Inventory turnover	4.87	4.28	4.16	3.78	3.8
ROE	0.08	0.09	0.14	0.14	0.09
Capex per share	-0.89	-1.12	-1.81	-1.54	-1.88

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-29	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	11.48	9.83	9.71	9.3	8.66
Net income per share	3.06	1.99	1.5	1.53	1.46
Operating cash flow per share	3.49	2.67	2.61	2.26	2.19
Free cash flow per share	3.03	2.29	2.15	1.77	1.65
Cash per share	8.22	10.12	11.63	16.6	7.93
Book value per share	68.71	70.58	70.14	70.88	72.3
Tangible book value per share	-13.01	-11.44	-9.72	-7.47	-11.98
Share holders equity per share	68.71	70.58	70.14	70.88	72.3
Interest debt per share	27.36	28.79	28.54	31.42	25.23
Market cap	170.11B	162.04B	156.26B	162.41B	172.98B
Enterprise value	184.85B	175.59B	168.66B	173.29B	186.65B
P/E ratio	19.05	27.94	35.32	35.96	40.08
Price to sales ratio	20.33	22.61	21.83	23.63	27.01
POCF ratio	66.95	83.22	81.13	97.13	106.84
PFCF ratio	76.9	96.91	98.58	124.26	142.14
P/B Ratio	3.4	3.15	3.02	3.1	3.23
PTB ratio	3.4	3.15	3.02	3.1	3.23
EV to sales	22.09	24.5	23.57	25.21	29.14
Enterprise value over EBITDA	64.41	74.69	84.71	86.99	97.88
EV to operating cash flow	72.75	90.18	87.57	103.64	115.29
EV to free cash flow	83.57	105.02	106.41	132.59	153.37
Earnings yield	0.01	0.01	0.01	0.01	0.01
Free cash flow yield	0.01	0.01	0.01	0.01	0.01
Debt to equity	0.4	0.41	0.41	0.44	0.35
Debt to assets	0.24	0.25	0.25	0.26	0.22
Net debt to EBITDA	5.14	5.76	6.23	5.46	7.17
Current ratio	1.89	1.89	2.08	2.26	1.68
Interest coverage	34.4	26.38	21.33	19.7	16.64
Income quality	1.14	1.34	1.74	1.48	1.44
Dividend Yield	0	0	0	0	0
Payout ratio	0.09	0.14	0.2	0.18	0.19
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.05	0.06	0.06	0.06	0.06
Intangibles to total assets	0.68	0.7	0.69	0.66	0.74
Capex to operating cash flow	-0.13	-0.14	-0.18	-0.22	-0.25
Capex to revenue	-0.04	-0.04	-0.05	-0.05	-0.06
Capex to depreciation	-0.58	-0.49	-0.61	-0.66	-0.82
Stock based compensation to revenue	0	0.01	0.02	0.01	0
Graham number	68.8	56.18	48.66	49.35	48.71
ROIC	0.03	0.02	0.02	0.02	0.02
Return on tangible assets	0.08	0.06	0.04	0.04	0.05
Graham Net	-30.59	-29.13	-26.94	-24.86	-27.52
Working capital	7.49B	7.8B	9.06B	11.84B	5.66B
Tangible asset value	-7.01B	-8.35B	-7.17B	-5.53B	-8.86B
Net current asset value	-18.38B	-17.02B	-15.72B	-14.11B	-17.06B
Invested capital	0.4	0.41	0.41	0.44	0.35
Average receivables	5.14B	5.1B	4.26B	4.2B	4.42B
Average payables	2.24B	2.19B	2.02B	1.93B	1.83B
Average inventory	3.17B	3.25B	3.28B	3.1B	2.81B
Days sales outstanding	63.23	54.16	52.8	55.01	65.16
Days payables outstanding	60.24	66.96	56.5	59.33	60.53
Days of inventory on hand	81.6	108.86	91.94	94.73	88.9
Receivables turnover	1.42	1.66	1.7	1.64	1.38
Payables turnover	1.49	1.34	1.59	1.52	1.49
Inventory turnover	1.1	0.83	0.98	0.95	1.01
ROE	0.04	0.03	0.02	0.02	0.02
Capex per share	-0.45	-0.38	-0.46	-0.49	-0.54

0R2B.L Dividend History

0R2B.L Frequently Asked Questions

What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol 0R2B.L

What is Danaher Corporation stock quote today ?

Danaher Corporation stock price is $238.23 today.

Is Danaher Corporation stock public?

Yes, Danaher Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 37.09K
Market Capitalization 177.92B
Employee 61K
CEO Mr. Rainer M. Blair
Headquarters Washington,DC,US
IPO Date 2014-11-05
Website https://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.